Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,459.00    -46.00 (-1.84%)
Bid:
2,457.00
Ask:
2,459.00
Spread: 2.00 (0.081%)
Market Cap: £21.86b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Director/PDMR Shareholding

17 Jun 2025 14:00

RNS Number : 2159N
Experian plc
17 June 2025
Ā 

Experian plc

Ā 

Ā 

Director/PDMR Shareholding

Ā 

Ā 

17 June 2025 - Experian plc, the global data and technology company, hereby notifies the market that it has received notification (made under article 19.1 of the UK Market Abuse Regulation ("MAR")) of the following transactions in its ordinary shares of 10 US cents each ("ordinary shares") by directors of the Company.

Ā 

Co-Investment Plan

Ā 

In accordance with the terms of the Experian Co-Investment Plan, the Company made awards over its ordinary shares on 13 June 2025 to certain directors by reference to a price of 3,746.27 pence per share. The awards of deferred matching ordinary shares are subject to performance conditions and the maximum numbers of shares that could vest in the case of each director are set out below.

Name of director/PDMR

Number of deferred

ordinary shares

Maximum number of deferred matching ordinary shares

Brian Cassin

30,157

113,802

Lloyd Pitchford

21,221

80,079

Ā 

Note: The deferred ordinary share awards for Brian Cassin and Lloyd Pitchford were calculated with reference to their bonuses net of tax. All deferred matching ordinary share awards were calculated on a gross basis and will be taxed at the point of vesting.

Ā 

Performance Share Plan

Ā 

In accordance with the terms of the Experian Performance Share Plan, the Company made awards over its ordinary shares on 13 June 2025 to certain directors by reference to a price of 3,775.30 pence per share. The awards are subject to performance conditions and the maximum number of shares that could vest in the case of each director is set out below.

Ā 

Name of director/PDMR

Maximum number

of ordinary shares

Brian Cassin

71,516

Lloyd Pitchford

40,791

Ā 

The following individual notifications are made in accordance with Article 19.3 of MAR.

Ā 

Ā 

1 - Details of the person discharging managerial responsibilities / person closely associated

Ā 

Ā 

Ā 

Natural Person

Brian Cassin

Ā 

Ā 

2 - Reason for the notification

Ā 

Ā 

Ā 

Position/status

Director and Chief Executive Officer

Ā 

Ā 

Initial notification / Amendment

Initial Notification

Ā 

Ā 

3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Ā 

Ā 

Ā 

Ā 

Full name of the entity

Experian plc

Legal Entity Identifier code

635400RXXHHYT1JTSZ26

Ā 

Ā 

Ā 

4 - Details of the transaction(s)

Ā 

Ā 

Ā 

Ā 

Description of the financial instrument, type of instrument

Ā 

Ordinary shares of US 10 cents each in Experian plc

Ā 

Identification Code

GB00B19NLV48

Ā 

Ā 

Nature of transaction

(1) Acquisition of shares, being the award of Invested Shares ("deferred ordinary shares") for market value under the Experian Co-Investment Plan.

Ā 

(2) Grant of a conditional right to receive shares for nil consideration, being the grant of a Matching Award ("deferred matching ordinary shares") under the Experian Co-Investment Plan.

Ā 

(3) Grant of a conditional right to receive shares for nil consideration, being the grant of an award under the Experian Performance Share Plan.

Ā 

Ā 

Currency

GBP

Ā 

Ā 

Prices(s) and volumes(s)

Transaction

Price

Volume

No (1)

3,746.27 pence

30,157

No (2)

Nil

113,802

No (3)

Nil

71,516

Ā 

Ā 

Aggregated Information

Transaction

Price

Volume

No (1)

3,746.27 pence

30,157

No (2) and (3)

Nil

185,318

Ā 

Ā 

Date of Transaction

Ā 

2025-06-13

Ā 

Ā 

Place of transaction

Acquisition: XLON

Grant of conditional rights: Outside a trading venue

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

1 - Details of the person discharging managerial responsibilities / person closely associated

Ā 

Ā 

Ā 

Natural Person

Lloyd Pitchford

Ā 

Ā 

2 - Reason for the notification

Ā 

Ā 

Ā 

Position/status

Director and Chief Financial Officer

Ā 

Ā 

Initial notification / Amendment

Initial Notification

Ā 

Ā 

3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Ā 

Ā 

Ā 

Full name of the entity

Experian plc

Ā 

Ā 

Legal Entity Identifier code

635400RXXHHYT1JTSZ26

Ā 

Ā 

Ā 

Ā 

4 - Details of the transaction(s)

Ā 

Ā 

Ā 

Ā 

Description of the financial instrument, type of instrument

Ā 

Ordinary shares of US 10 cents each in Experian plc

Ā 

Identification Code

GB00B19NLV48

Ā 

Ā 

Nature of transaction

(1) Acquisition of shares, being the award of Invested Shares ("deferred ordinary shares") for market value under the Experian Co-Investment Plan.

Ā 

(2) Grant of a conditional right to receive shares for nil consideration, being the grant of a Matching Award ("deferred matching ordinary shares") under the Experian Co-Investment Plan.

Ā 

(3) Grant of a conditional right to receive shares for nil consideration, being the grant of an award under the Experian Performance Share Plan.

Ā 

Ā 

Currency

GBP

Ā 

Ā 

Prices(s) and volumes(s)

Transaction

Price

Volume

No (1)

3,746.27 pence

21,221

No (2)

Nil

80,079

No (3)

Nil

40,791

Ā 

Ā 

Aggregated Information

Transaction

Price

Volume

No (1)

3,746.27 pence

21,221

No (2) and (3)

Nil

120,870

Ā 

Ā 

Date of Transaction

Ā 

2025-06-13

Ā 

Ā 

Place of transaction

Acquisition: XLON

Grant of conditional rights: Outside a trading venue

Ā 

Ā 

Ā 

Ā 

Experian

Claire Murphy Deputy Company Secretary +353 (0) 87 421 3311

Ā 

Ā 

About Experian

Ā 

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

Ā 

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

Ā 

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 23,300 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

Ā 

Ā 

Ā 

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
DSHGPUBGQUPAGGM
Date   Source Headline
1st Jun 202110:13 amRNSDirector Declaration
26th May 20214:22 pmRNSTransaction in Own Shares
26th May 20219:15 amRNSAdditional Listing
20th May 202110:22 amRNSDirector/PDMR Shareholding
20th May 20217:49 amRNSTransaction in Own Shares
19th May 20212:41 pmRNSDirector/PDMR Shareholding
19th May 202112:20 pmRNSShare repurchases
19th May 20217:00 amRNSFull-year financial report
30th Apr 20213:19 pmRNSTotal Voting Rights
14th Apr 20219:15 amRNSAdditional Listing
31st Mar 202110:11 amRNSTotal Voting Rights
24th Mar 20219:00 amRNSDirectorate Change
19th Mar 202110:57 amRNSBlock listing Interim Review
18th Mar 20214:40 pmRNSDirector Declaration
10th Mar 20219:15 amRNSAdditional Listing
26th Feb 20212:26 pmRNSTotal Voting Rights
17th Feb 202110:53 amRNSBlock listing
8th Feb 20217:00 amRNSResponse to media speculation in Brazil
29th Jan 20213:03 pmRNSTotal Voting Rights
19th Jan 20217:00 amRNSExperian plc, Trading update, third quarter
15th Jan 20215:45 pmRNSFirst interim dividend
4th Jan 202111:16 amRNSTotal Voting Rights
18th Dec 202011:00 amRNSElections for first interim dividend
9th Dec 202010:00 amRNSAdditional Listing
30th Nov 20203:40 pmRNSTotal Voting Rights
26th Nov 202011:30 amRNSLong-Term Incentive Plans – Performance Measures
25th Nov 20209:39 amRNSAdditional Listing
17th Nov 20203:36 pmRNSDirector/PDMR Shareholding
17th Nov 20207:00 amRNSHalf-year Report
30th Oct 20203:14 pmRNSTotal Voting Rights
27th Oct 202012:32 pmRNSUK marketing services - ICO enforcement notice
21st Oct 20209:08 amRNSAdditional Listing
30th Sep 20202:17 pmRNSTotal Voting Rights
28th Sep 20206:15 pmRNSBond Issue
25th Sep 202012:30 pmRNSHolding(s) in Company
23rd Sep 202012:02 pmRNSDirector/PDMR Shareholding
18th Sep 20202:58 pmRNSBlock listing Interim Review
9th Sep 20209:22 amRNSAdditional Listing
8th Sep 20207:00 amRNSTrading update, Q2 revenue expectations revised
1st Sep 202010:25 amRNSTotal Voting Rights
28th Aug 202010:00 amRNSDirector/PDMR Shareholding
26th Aug 20209:15 amRNSAdditional Listing
19th Aug 20206:01 pmRNSExperian South Africa curtails fraud incident
19th Aug 20209:12 amRNSAdditional Listing
31st Jul 202012:55 pmRNSTotal Voting Rights
31st Jul 202012:00 pmRNSDirector/PDMR Shareholding
22nd Jul 202011:38 amRNSResult of AGM
16th Jul 20207:00 amRNSExperian PLC Trading update, first quarter
3rd Jul 20205:41 pmRNSSecond Interim Dividend
1st Jul 20202:00 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.